Clinical Trial Update: Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients [NA]

View source ↗

Summary

An update on a clinical trial assessing SIR-Spheres Y-90 resin microspheres for unresectable hepatocellular carcinoma, focusing on duration of response (DoR) an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• SIR-Spheres Y-90 resin microspheres (yttrium-90 resin microspheres)

Snippet

Sponsor: Sirtex Medical | Conditions: Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma | NA | Status: ACTIVE_NOT_RECRUITING